A Nanostructured Silica-Lipid Hybrid to Facilitate Oral SN-38-based Chemotherapy

E-ISSN： 2210-304x|6|1|11-17

ISSN： 2210-3031

Source： Drug Delivery Letters, Vol.6, Iss.1, 2016-10, pp. : 11-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

By Fricker Gert Kromp Torsten Wendel Armin Blume Alfred Zirkel Jürgen Rebmann Herbert Setzer Constanze Quinkert Ralf-Olaf Martin Frank Müller-Goymann Christel

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1469-1486

Springer Publishing Company

Access to resources Recommend Favorite

Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib

By Joshi M. Patravale V.

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 8, 2006-09 ,pp. : 911-918

Informa Healthcare

Access to resources Recommend Favorite

Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics

Current Drug Metabolism, Vol. 16, Iss. 8, 2015-10 ,pp. : 633-644

Bentham Science Publishers

Access to resources Recommend Favorite

Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations

By Mercke Odeberg J. Lignell A. Pettersson A. Hoglund P.

European Journal of Pharmaceutical Sciences, Vol. 19, Iss. 4, 2003-07 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite

Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism

Current Drug Metabolism, Vol. 16, Iss. 3, 2015-08 ,pp. : 200-210

Bentham Science Publishers

Access to resources Recommend Favorite